Evidence map›Paper›PMID 17203242›Full record

ArticleMolecular and cellular biochemistry2007

Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis.

Souichi Furuhata, Kiyoshi Ando, Masayuki Oki, Kazunori Aoki, Shunsuke Ohnishi, Kazuhiko Aoyagi, Hiroki Sasaki, Hiromi Sakamoto, Teruhiko Yoshida, Shumpei Ohnami

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Mechanisms of glioma-associated neovascularization.The American journal of pathology · 2012
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Endothelial progenitor cells in neovascularization of infarcted myocardium.Journal of molecular and cellular cardiology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Souichi FuruhataGenetics Division, National Cancer Center Research Institute, Tokyo, Japan.
Kiyoshi Ando
Masayuki Oki
Kazunori Aoki
Shunsuke Ohnishi
Kazuhiko Aoyagi
Hiroki Sasaki
Hiromi Sakamoto
Teruhiko Yoshida
Shumpei Ohnami
National Cancer Research Institute · GBTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the many tissue stem or progenitor cells recently being unveiled, endothelial progenitor cells (EPCs) have attracted particular attention, not only because of their cardinal role in vascular biology and embryology but also because of their potential use in the therapeutic development of a variety of postnatal diseases, including cardiovascular and peripheral vascular disorders and cancer. The aim of this study is to provide some basic and comprehensive information on gene expression of EPCs to characterize the cells in molecular terms. Here, we focus on EPCs derived from CD34-positive mononuclear cells of human umbilical cord blood. The EPCs were purified and expanded in culture and analyzed by a high-density oligonucleotide microarray and real-time RT-PCR analysis. We identified 169 up-regulated and 107 down-regulated genes in the EPCs compared with three differentiated endothelial cells of human umbilical vein endothelial cells (HUVEC), human lung microvascular endothelial cells (LMEC) and human aortic endothelial cells (AoEC). It is expected that the obtained list include key genes which are critical for EPC function and survival and thus potential targets of EPC recognition in vivo and therapeutic modulation of vasculogenesis in cancer as well as other diseases, in which de novo vasculogenesis plays a crucial role. For instance, the list includes Syk and galectin-3, which encode protein tyrosine kinase and beta-galactoside-binding protein, respectively, and are expressed higher in EPCs than the three control endothelial cells. In situ hybridization showed that the genes were expressed in isolated cells in the fetal liver at E11.5 and E14.5 of mouse development.

Indexed as

Gene Expression ProfilingOligonucleotide Array Sequence AnalysisAnimalsAntigens, CD34BiomarkersCells, CulturedCluster AnalysisDown-RegulationEmbryo, MammalianEndothelial CellsGalectin 3HumansIntracellular Signaling Peptides and ProteinsLeukocytes, MononuclearMiceProtein-Tyrosine KinasesAntigens, CD34BiomarkersGalectin 3Intracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesSyk KinaseSYK protein, humanSyk protein, mouse

Identifiers

PMID17203242
OpenAlexW2094558882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.